Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane

被引：0
|
作者：
Mavinkurve-Groothuis, Annelies M. C. [1 ]
de Baat, Esmee C. [1 ]
Feijen, Elizabeth A. M. [1 ]
Kremer, Leontien C. M. [1 ,2 ,3 ]
Armenian, Saro H. [4 ]
Mulder, Renee L. [1 ]
van Dalen, Elvira C. [1 ]
机构：
[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Cardiol, Utrecht, Netherlands
[3] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Amsterdam, Netherlands
[4] City Hope Natl Med Ctr, Natl Med Ctr, Populat Sci, Duarte, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷 / 10期
关键词：
D O I：
10.1002/pbc.30604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reply to Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
    Bertorello, Nicoletta
    Luksch, Roberto
    Bisogno, Gianni
    Haupt, Riccardo
    Spallarossa, Paolo
    Cenna, Rosita
    Fagioli, Franca
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [2] Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane
    Bertorello, Nicoletta
    Luksch, Roberto
    Bisogno, Gianni
    Haupt, Riccardo
    Spallarossa, Paolo
    Cenna, Rosita
    Fagioli, Franca
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [3] Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
    de Baat, Esmee C.
    Mulder, Renee L.
    Armenian, Saro
    Feijen, Elizabeth A. M.
    Grotenhuis, Heynric
    Hudson, Melissa M.
    Mavinkurve-Groothuis, Annelies M. C.
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [4] Economic assessment of dexrazoxane in prophylaxis of cardiotoxicity in children undergoing chemotherapy with anthracyclines
    Alves Fernandes, Ricardo Ribeiro
    de Mello Vianna, Cid Manso
    de Freitas, Paulo Gomes
    Guerra, Renata Leborato
    Correa, Flavia Miranda
    CADERNOS DE SAUDE PUBLICA, 2019, 35 (09):
  • [5] Preventing the cardiotoxicity of anthracyclines by dexrazoxane - A real breakthrough
    Hellmann, K
    BRITISH MEDICAL JOURNAL, 1999, 319 (7217): : 1085 - 1086
  • [6] Should anthracyclines and dexrazoxane be used for children with cancer?
    van Dalen, Elvira C.
    van den Berg, Henk
    Raphael, Martine F.
    Caron, Huib N.
    Kremer, Leontien C.
    LANCET ONCOLOGY, 2011, 12 (01): : 12 - 13
  • [7] Dexrazoxane as a Cardioprotectant in Children Receiving Anthracyclines
    Sepe, Dana M.
    Ginsberg, Jill P.
    Balis, Frank M.
    ONCOLOGIST, 2010, 15 (11): : 1220 - 1226
  • [8] EVALUATION OF EARLY DEXRAZOXANE USE AND CARDIOTOXICITY RISK IN PATIENTS WITH SOFT-TISSUE SARCOMA TREATED WITH ANTHRACYCLINES
    Jang, Kristine
    Wallins, Joseph S.
    Movva, Sujana
    Tsay, Annie
    Liu, Jennifer E.
    Yu, Anthony F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2351 - 2351
  • [9] Cardiotoxicity in patients treated with anthracyclines
    Santoro, M
    Santoro, A
    Maiorino, L
    BALKAN CONGRESS OF ONCOLOGY, 1996, : 55 - 57
  • [10] Ameliorating anthracycline cardiotoxicity in children with cancer: Clinical trials with dexrazoxane
    Wexler, LH
    SEMINARS IN ONCOLOGY, 1998, 25 (04) : 86 - 92
12345